Phase 1/2 study of the combination of gemcitabine and nedaplation for treatment of previously untreated advanced squamous cell lung cancer
Phase of Trial: Phase I/II
Latest Information Update: 09 May 2017
At a glance
- Drugs Gemcitabine (Primary) ; Nedaplatin (Primary)
- Indications Lung cancer
- Focus Adverse reactions; Therapeutic Use
- 08 Jun 2009 Status changed from not stated to recruiting.
- 08 Jun 2009 New trial record.